TSCAN THERAPEUTICS, INC. Fair Value, Assets, Level 2 to Level 1 Transfers, Amount
TSCAN THERAPEUTICS, INC. (TCRX) had Fair Value, Assets, Level 2 to Level 1 Transfers, Amount of $0 as of 2022-03-31, per its 10-Q filed 2022-05-12.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssetsLevel2ToLevel1TransfersAmount · last filed 2022-05-12
- 2022-03-31: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
- 2021-12-31: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
- 2021-09-30: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
- 2021-06-30: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
| Period end | Fair Value, Assets, Level 2 to Level 1 Transfers, Amount |
|---|---|
| 2022-03-31 | $0.00 10-Q · filed 2022-05-12 |
| 2021-12-31 | $0.00 10-K · filed 2022-03-09 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-10 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-19 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B |